$2.71
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Galectin Therapeutics (NASDAQ:GALT) Stock, Earnings Estimates, EPS, And Revenue
Galectin Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 11
EPS Estimate
$-0.200
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of Galectin Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Galectin Therapeutics (GALT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-13 | $-0.20 | $-0.16 | -25.0 % |
| Mar 2024 | 2024-05-15 | $-0.19 | $-0.16 | -18.8 % |
| Dec 2023 | 2024-03-29 | $-0.16 | $-0.16 | 0.00 % |
| Sep 2023 | 2023-11-13 | $-0.24 | $-0.16 | -50.0 % |
Galectin Therapeutics (GALT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Galectin Therapeutics (NASDAQ:GALT) reporting earnings?
Galectin Therapeutics (GALT) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 13, 2024 for Q2.
What were the latest earnings per share (EPS) for Galectin Therapeutics (NASDAQ:GALT)?
The Actual EPS was $-0.20, which missed the estimate of $-0.16.
What were Galectin Therapeutics’s (NASDAQ:GALT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.